AVITA Medical, Inc. (RCEL) › Operating Cash FlowAVITA Medical, Inc. (RCEL) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2018: -$12.96M2019: -$19.25M2020: -$22.75M2021: -$25.90M2022: -$19.09M2023: -$38.01M2024: -$48.94M2025: -$31.20M-$31.20M2018Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$31.20M+36.3%2024-$48.94M-28.7%2023-$38.01M-99.1%2022-$19.09M+26.3%2021-$25.90M-13.9%2020-$22.75M-18.2%2019-$19.25M-48.5%2018-$12.96M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share